ABBOTT PARK, Ill., Jan. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) has once again been named to the S&P 500 Dividend Aristocrats and S&P High Yield Dividend Aristocrats Indices.
The S&P 500 Dividend Aristocrats comprises companies in the S&P 500 that have increased dividends every year for the past 25 consecutive years. The S&P High Yield Dividend Aristocrats includes companies within the S&P Composite 1500 with 20 straight years of dividend increases. Abbott has increased its dividend payout for 40 consecutive years.
Abbott's former research-based pharmaceutical business, which became the independent biopharmaceutical company AbbVie on Jan. 1, 2013, was also named to both lists based on the history of the combined companies' dividend record.
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.